Robert C Strunk1, Robyn T Cohen2, Benjamin P Cooper3, Mark Rodeghier4, Fenella J Kirkham5, John O Warner6, Janet Stocks5, Jane Kirkby5, Irene Roberts6, Carol L Rosen7, Daniel I Craven7, Michael R DeBaun8. 1. Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, MO. Electronic address: strunk@kids.wustl.edu. 2. Department of Pediatrics, Boston Medical Center/Boston University School of Medicine, Boston, MA. 3. Brown School of Social Work, Washington University, St Louis, MO. 4. Independent Statistician, Chicago, IL. 5. University College, London Institute of Child Health, London, United Kingdom. 6. Department of Paediatrics, Imperial College and Imperial College Healthcare NHS Trust, London, United Kingdom. 7. Department of Pediatrics, Case Western Reserve University School of Medicine, Rainbow Babies and Children's Hospitals, University Hospitals Case Medical Center, Cleveland, OH. 8. Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN.
Abstract
OBJECTIVE: To identify factors associated with asthma associated with increased sickle cell anemia (SCA). STUDY DESIGN: Children with SCA (N = 187; mean age 9.6 years, 48% male) were classified as having "asthma" based on parent report of physician diagnosis plus prescription of asthma medication (n = 53) or "no asthma" based on the absence of these features (n = 134). Pain and acute chest syndrome (ACS) events were collected prospectively. RESULTS: Multiple variable logistic regression model identified 3 factors associated with asthma: parent with asthma (P = .006), wheezing causing shortness of breath (P = .001), and wheezing after exercise (P < .001). When ≥2 features were present, model sensitivity was 100%. When none of the features were present, model sensitivity was 0%. When only 1 feature was present, model sensitivity was also 0%, and presence of ≥2 of positive allergy skin tests, airway obstruction on spirometry, and bronchodilator responsiveness did not improve clinical utility. ACS incident rates were significantly higher in individuals with asthma than in those without asthma (incident rate ratio 2.21, CI 1.31-3.76), but pain rates were not (incident rate ratio 1.28, CI 0.78-2.10). CONCLUSIONS: For children with SCA, having a parent with asthma and specific wheezing symptoms are the best features to distinguish those with and without parent report of a physician diagnosis of asthma and to identify those at higher risk for ACS events. The value of treatment for asthma in the prevention of SCA morbidity needs to be studied.
OBJECTIVE: To identify factors associated with asthma associated with increased sickle cell anemia (SCA). STUDY DESIGN: Children with SCA (N = 187; mean age 9.6 years, 48% male) were classified as having "asthma" based on parent report of physician diagnosis plus prescription of asthma medication (n = 53) or "no asthma" based on the absence of these features (n = 134). Pain and acute chest syndrome (ACS) events were collected prospectively. RESULTS: Multiple variable logistic regression model identified 3 factors associated with asthma: parent with asthma (P = .006), wheezing causing shortness of breath (P = .001), and wheezing after exercise (P < .001). When ≥2 features were present, model sensitivity was 100%. When none of the features were present, model sensitivity was 0%. When only 1 feature was present, model sensitivity was also 0%, and presence of ≥2 of positive allergy skin tests, airway obstruction on spirometry, and bronchodilator responsiveness did not improve clinical utility. ACS incident rates were significantly higher in individuals with asthma than in those without asthma (incident rate ratio 2.21, CI 1.31-3.76), but pain rates were not (incident rate ratio 1.28, CI 0.78-2.10). CONCLUSIONS: For children with SCA, having a parent with asthma and specific wheezing symptoms are the best features to distinguish those with and without parent report of a physician diagnosis of asthma and to identify those at higher risk for ACS events. The value of treatment for asthma in the prevention of SCA morbidity needs to be studied.
Authors: Joshua J Field; Janet Stocks; Fenella J Kirkham; Carol L Rosen; Dennis J Dietzen; Trisha Semon; Jane Kirkby; Pamela Bates; Sinziana Seicean; Michael R DeBaun; Susan Redline; Robert C Strunk Journal: Chest Date: 2010-08-19 Impact factor: 9.410
Authors: R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: Joanna E MacLean; Eshetu Atenafu; Melanie Kirby-Allen; Ian B MacLusky; Derek Stephens; Hartmut Grasemann; Padmaja Subbarao Journal: Am J Respir Crit Care Med Date: 2008-09-05 Impact factor: 21.405
Authors: Carol L Rosen; Michael R Debaun; Robert C Strunk; Susan Redline; Sinziana Seicean; Daniel I Craven; Johanna C D Gavlak; Olu Wilkey; Baba Inusa; Irene Roberts; R Lucas Goodpaster; Beth Malow; Mark Rodeghier; Fenella J Kirkham Journal: Pediatrics Date: 2014-07-14 Impact factor: 7.124
Authors: Sara C Sadreameli; Rachel O Alade; Peter J Mogayzel; Sharon McGrath-Morrow; John J Strouse Journal: Pediatr Allergy Immunol Pulmonol Date: 2017-12-01 Impact factor: 1.349
Authors: Shaina M Willen; Mark Rodeghier; Robert C Strunk; Leonard B Bacharier; Carol L Rosen; Fenella J Kirkham; Michael R DeBaun; Robyn T Cohen Journal: Br J Haematol Date: 2018-01-24 Impact factor: 6.998
Authors: Shaina M Willen; Robyn Cohen; Mark Rodeghier; Fenella Kirkham; Susan S Redline; Carol Rosen; Jane Kirkby; Michael R DeBaun Journal: Am J Hematol Date: 2018-01-25 Impact factor: 10.047
Authors: Aravind Yadav; Fernando F Corrales-Medina; James M Stark; S Shahrukh Hashmi; Mary P Carroll; Keely G Smith; Kristen M Meulmester; Deborah L Brown; Cindy Jon; Ricardo A Mosquera Journal: Pediatr Allergy Immunol Pulmonol Date: 2015-09-01 Impact factor: 1.349
Authors: Jeffrey Glassberg; Caterina Minnitti; Caroline Cromwell; Lawrence Cytryn; Thomas Kraus; Gwen S Skloot; Jason T Connor; Adeeb H Rahman; William J Meurer Journal: Am J Hematol Date: 2017-06-05 Impact factor: 10.047
Authors: Robyn T Cohen; Mark Rodeghier; Fenella J Kirkham; Carol L Rosen; Jane Kirkby; Michael R DeBaun; Robert C Strunk Journal: J Allergy Clin Immunol Date: 2016-08-09 Impact factor: 10.793
Authors: Michael R DeBaun; Mark Rodeghier; Robyn Cohen; Fenella J Kirkham; Carol L Rosen; Irene Roberts; Ben Cooper; Janet Stocks; Olu Wilkey; Baba Inusa; John O Warner; Robert C Strunk Journal: Am J Hematol Date: 2014-08-27 Impact factor: 10.047
Authors: Najibah A Galadanci; Wayne H Liang; Aisha A Galadanci; Muktar H Aliyu; Binta W Jibir; Ibraheem M Karaye; Baba P Inusa; Sten H Vermund; Robert C Strunk; Michael R DeBaun Journal: J Pediatr Hematol Oncol Date: 2015-01 Impact factor: 1.289